‘Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review’. Journal of Health Management and Pharmacy Exploration 3, no. 1 (februari 27, 2025). Geraadpleegd augustus 24, 2026. https://shmpublisher.com/index.php/johmpe/article/view/547.